European Medicines Agency: More than 300 cases of rare blood clot events worldwide
AMSTERDAM, April 20 (Reuters) - The European Union’s drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of COVID-19 vaccines.
There were 287 occurrences with the AstraZeneca vaccine, eight with Johnson & Johnson’s shot, 25 for Pfizer and five for Moderna, said Peter Arlett, Head of Data Analytics at the European Medicines Agency (EMA).
Reporting by Anthony Deutsch and Toby Sterling Editing by Gareth JOnes
Our Standards: The Thomson Reuters Trust Principles.